The National Hospital for Neurology and Neurosurgery is a neurological hospital in Queen Square, London. It is part of the University College London Hospitals NHS Foundation Trust. It was the first hospital to be established in England dedicated exclusively to treating the diseases of the nervous system.

There are 244 beds in National Hospital for Neurology and Neurosurgery.

During the past decade, National Hospital for Neurology and Neurosurgery conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 20 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 14 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital for Neurology and Neurosurgery" #1 sponsor was "University College, London" with 12 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "University College London Hospitals" with 4 trials sponsored, "Washington University School of Medicine" with 4 trials sponsored and "BioMarin Pharmaceutical" with 4 trials sponsored. Other sponsors include 53 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital for Neurology and Neurosurgery" #1 collaborator was "University of Rochester" with 5 trials as a collaborator, "Alzheimer's Association" with 4 trials as a collaborator, "Children's Hospital of Philadelphia" with 4 trials as a collaborator, "Muscular Dystrophy Association" with 4 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 4 trials as a collaborator. Other collaborators include 84 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital for Neurology and Neurosurgery" are "Alzheimer's Disease" (5 trials), "Epilepsy" (5 trials), "Alzheimers Disease" (4 trials), "Alzheimers Disease, Familial" (4 trials) and "Dementia" (4 trials). Many other conditions were trialed in "National Hospital for Neurology and Neurosurgery" in a lesser frequency.

Most popular intervention types in "National Hospital for Neurology and Neurosurgery" are "Drug" (47 trials), "Device" (12 trials), "Other" (9 trials), "Biological" (5 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Gantenerumab" (3 trials), "Matching Placebo (Gantenerumab)" (3 trials), "ampreloxetine" (3 trials) and "E2814" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital for Neurology and Neurosurgery" are 79 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "National Hospital for Neurology and Neurosurgery". undefined are not yet recruiting, 13 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in National Hospital for Neurology and Neurosurgery, 1 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital for Neurology and Neurosurgery, 10 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 13 trials that are defined as “Not Applicable".